Interleukin 4 Regulates G1 Cell Cycle Progression in Gastric Carcinoma Cells

Cancer Research

Volumn 54, Issue 4, 1994, Pages 1113-1118

  Morisaki, Takashi ^a   Uchiyama, Akihiko ^a   Yuzuki, Dale ^a   Essner, Richard ^a   Morton, Donald L ^a   Hoon, Dave S B ^a  

^a John Wayne Cancer Institute ^*  (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DOWN REGULATION; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CARCINOMA;

ADENOCARCINOMA; CYCLINS; G1 PHASE; GENES, MYC; HUMAN; INTERLEUKIN-4; PROTEIN P34CDC2; RETINOBLASTOMA PROTEIN; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028209441     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Paul, W.E., and Ohara, J. B-Cell stimulatory factor interleukin 4. Annu. Rev. Immunol., 5: 429-459, 1987.
2. Hoon, D.S.B., Banez, M., Okun, E., Morton, D.L., and Irie, R.F. Modulation of human melanoma cells by interleukin-4 and in combination with y-interferon or a-tumor necrosis factor. Cancer Res., 51: 2002-2008, 1991.
3. Hoon, D.S.B., Okun, E., Banez, M., Irie, R.R., and Morton, D.L. Interleukin 4 alone and with “/-interferon or a-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinoma. Cancer Res., 51: 5687-5693, 1991.
4. Obiri, N.I., Hillman, G.G., Haas, G.P., Sud, S., and Puri, R.K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J. Clin. Invest., 91: 88-93, 1993.
5. Morisaki, T., Yuzuki, D.H., Lin, R.T., Foshag, L.J., Morton, D.L., and Hoon, D.S.B. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4. Cancer Res., 52: 6059-6065, 1992.
6. Toi, M., Bicknell, R., and Harris, A.L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res., 52: 275-279, 1992.
7. Okabe, M., Kunieda, Y., Sugiwura, T., Tanaka, M., Miyagishima, T., Saiki, I., Minagawa, T., Kurosawa, M., Itaya, T., and Miyazaki, T. Inhibitory effect of interleukin-4 on the in vitro growth of Ph1-positive acute lymphoblastic leukemia cells. Blood, 6: 1574-1580, 1991.
8. Dedrance, T., Fluckigen, A.C., Rosi, J.R., Magaid, J.P., Sotto, J.J., and Banchereau, J. Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood, 79: 990-996, 1992.
9. Pandrau, Q., Saeland, S., Duront, I., Manel, A.M., Zabot, M.T., Philippe, N., and Banchereau, J. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J. Clin. Invest., 90: 1697-1706, 1992.
10. Akashi, K., Shibuya, T., Harada, M., Takamatsu, Y., Uike, N., Eto, J., and Niho, Y Interleukin 4 suppress the spontaneous growth of chronic tnyelomonocytic leukemia cells. J. Clin. Invest., 88: 223-230, 1992.
11. Pardee, A.B. Gi events and regulation of cell proliferation. Science (Washington DC), 246: 603-608, 1989.
12. Kato, G.J., and Dang, C.V. Function of the c-myc oncoprotein. FASEB J., 6: 3065-3072, 1992.
13. Prochownik, E.V., and Kukowska, J. Deregulated expression of c-myc by murine erythroleukemia cells prevent differentiation. Nature (Lond.), 322: 848-850, 1986.
14. DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.M., and Livingston, D.M. The product of the retinoblastoma susceptibility genes has properties of a cell cycle regulatory element. Cell, 58: 1085-1095, 1989.
15. Sager, R. Tumor suppressor genes in the cell cycle. Curr. Opin. Cell Biol., 4: 144-160, 1992.
16. Heikkila, R., Schwab, B., Wickstrom, E., Loko, S.L., Pluznid, D.H., Watt, R., and Neckers, L.M. A c-myc antisense oligodeoxynucleotide inhibits entry S phase but not progress from G0 to Gi. Nature (Lond.), 328: 445-449, 1987.
17. Resnitzky, D., Tiefenbrun, N., Berissi, H., and Kimchi, A. Interferon and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA, 89: 402-406, 1992.
18. Goodrich, D.W., Wang, N.P., Quin, Y.W., Lee, E.R., and Lee, W.H. The retinoblastoma gene product regulates progression through the G) phase of the cell cycle. Cell, 67: 293-302, 1991.
19. Shibuya, M., Yokota, J., and Ueyama, Y Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol. Cell. Biol., 5: 414-418, 1985.
20. Yanagihara, K., Seyama, T., Tsumuraya, M., Kamada, N., and Yokoro, K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res., 51: 381-386, 1991.
21. Freytag, S.O. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in Go/G]. Mol. Cell. Biol., 8: 1614-1624, 1988.
22. Lin B.T.Y., Grunenwald, S., Morla, A.O., Lee, W.H., and Wang, J.Y. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J., 10: 857-864, 1991.
23. Benedict, W., Xu, H.J., Hu, S.X., and Takahashi, R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J. Clin. Invest., 85: 988-993, 1990.
24. Meek, D.W., and Street, A.J. Nuclear protein phosphorylation and growth control. Biochem. J., 287: 1-15, 1992.
25. Norbury, C., and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-70, 1992.
26. Dalton, S. Cell cycle regulation of the human cdc2 gene. EMBO J., 11: 1797-1804, 1992.
27. Sherr, C.J. Mammalian G., cyclins. Cell, 73: 1059-1065, 1993.
28. Dowdy, S.F., Hinds, P.W., Louie, K., Reed, S.I., Arnold, A., and Weinberg, R.A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73: 499-511, 1993.
29. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, Jy., and Livingston, D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
30. Hunter, T., and Pines, J. Cyclins and cancer. Cell, 66: 1071-1074, 1991.
31. Xiong, Y., Connolly, T., Futcher, B., and Beach, D. Human D-type cyclin. Cell, 65: 691-699, 1991.
32. Chromczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
33. Wickstrom, E., Bacon, T.A., and Wickstrom, E.L. Down-regulation of c-MYC antigen expression in lymphocytes of Eju, -c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates. Cancer Res., 52: 6741-6745, 1992.
34. Ohmura, E., Okada, M., Onoda, N., Kamiya, Y., Murakami, Y., Tsushims, T., and Shizume, K. Insulin-like growth factor I and transforming growth factor a as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res., 50: 103-107, 1990.
35. Van der Burg, B., Rutteman, G.R., Blankenstein, M.A., de Laat, S.W., and van Ziolen, E.J.J. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J. Cell. Physiol., 134: 101-108, 1988.
36. Wang, L.M., Keegan, A.D., Li, W., Lienhard, G.E., Pacini, S., Gutkind, J.S., Myers, G.M., Sun, X.J., White, M.R., Aaronson, S.A., Paul, W.E., and Pierce, J.H. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA, 90: 4032-4036, 1993.
37. Goodrich, D.W., and Lee, W.H. Abrogation by c-myc of Gi phase arrest induced by RB protein but not by p. 3. Nature (Lond.), 360: 177-179, 1992.
38. Harada, N., Howard, M., and Miyajima, A. IL-4 receptor. In: H. Spits (ed.), IL-4: Structure and Function, pp. 34-54. Ann Arbor, MI: CRC Press, 1992.
39. Ito, M., Yasui, W., Eyo, E., Yokozaki, H., Nakayum, H., Ito, H., and Tahara, E. Growth inhibition of transforming growth factor 8 on human gastric carcinoma cells: receptor and postreceptor signaling. Cancer Res., 52: 295-300, 1992.
40. Rustigi, A.K., Dyson, N., and Hill, D. The c-myc oncoprotein forms a specific complex with the product of the retinoblastoma gene. Cold Spring Harbor Symp. Quant. Biol., 46: 163-167, 1991.
41. Takuwa, N., Zhou, W., Kumada, M., and Takuwa, Y Ca2+-dependent stimulation of retinoblastoma gene product phosphorylation and p. 4cdc2 kinase activation in serum-stimulated human fibroblasts. J. Biol. Chem., 268: 138-145, 1993.
42. Hu, Q., Lees, J.A., Buchkovich, K.J., and Harlow, E. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol. Cell. Biol., 12: 971-980, 1992.
43. Yasui, W., Ayhan, A., Kitadai, Y., Nishimura, K., Yokozaki, H., Ito, H., and Tahara, E. Increased expression of p. 4cdc2 and its kinase activity in human gastric and colonic carcinomas. Int. J. Cancer, 53: 36-41, 1993.
44. Lamimic, G.A., Fantl, V., Smith, R., Schuuring, E., Books, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. Dlls287, a putative oncogene on chromosome llql3 is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene, 6: 439-44, 1991.